Original Literature | Model OverView |
---|---|
Publication
Title
IFN regulation and functions in myeloid dendritic cells.
Affiliation
Department of Infectious, Parasitic and Immune-mediated Diseases, IstitutoSuperiore di Sanita, 00161 Rome, Italy. eliana.coccia@iss.it
Abstract
A central issue in dendritic cells (DC) biology is to understand how type I IFNsmodulate the immuno-regulatory properties of DC. In this review I will addressthis issue in light of the recent experimental evidence on the expression andfunction of these cytokines in myeloid DC. This knowledge may have importanttherapeutic implications in infectious and neoplastic diseases and open newperspectives in the use of IFNs as vaccine adjuvants and in the development ofDC-based vaccines.
PMID
18054516
|
Entity
Process
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m41
10
infinite
0
TRANSPATH | MO000000058 |
--
STAT1
--
MO000013119
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1357
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
protein remnants
--
MO000019479
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m360980
10
infinite
0
TRANSPATH | MO000019479 |
--
STAT1{p}
--
MO000019704
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4238
10
infinite
0
TRANSPATH | MO000019704 |
--
dsRNA
--
MO000022224
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m119368
10
infinite
0
TRANSPATH | MO000022224 |
--
dsRNA:TLR3:TRIF
--
MO000041437
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19305
10
infinite
0
TRANSPATH | MO000041437 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
IRF-3{p}
--
MO000041456
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19324
10
infinite
0
TRANSPATH | MO000041456 |
--
IRF-7{p}
--
MO000041457
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19325
10
infinite
0
TRANSPATH | MO000041457 |
--
TLR7
--
MO000042126
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19940
10
infinite
0
TRANSPATH | MO000042126 |
--
ATF-2:c-Jun
--
MO000055971
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m31298
10
infinite
0
TRANSPATH | MO000055971 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
CXCL11
--
e100
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m101
0
infinite
0
--
IL-12
--
e101
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m102
0
infinite
0
--
IL-12
--
e102
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m103
0
infinite
0
--
CD40
--
e103
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m104
0
infinite
0
--
Stat1
--
e104
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m105
0
infinite
0
--
target genes
--
e106
cso30:c:mRNA
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m107
0
infinite
0
--
IL-1beta
--
e107
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m108
0
infinite
0
--
CD40L
--
e108
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m109
0
infinite
0
--
peptidoglycan:TLR2
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
peptidoglycan
--
e12
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
lipopolypeptides
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
lipopolypeptides:TLR2
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
--
e15
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m15
0
infinite
0
--
--
e16
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m16
0
infinite
0
--
--
e17
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m17
0
infinite
0
--
flagellin:TLR5
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
ssRNA:TLR7
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
ssRNA
--
e20
cso30:c:Rna
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
ssRNA:TLR8
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
csml-variable:Double
m22
0
infinite
0
--
CpG DNA:TLR9
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
LPS:TLR4:MD2:TRAM
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
LPS:TLR4:MD2:TRAM:TRIF
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
imiquimod
--
e26
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
imiquimod:TLR7
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m27
0
infinite
0
--
R-848
--
e28
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
R-848:TLR8
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
R-848:TLR7
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
LPS:TLR4:MD2:MYD88
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
flagellin:TLR5:MYD88
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
peptidoglycan:TLR2:MYD88
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
ssRNA:TLR7:MYD88
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
ssRNA:TLR8:MYD88
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
CpG DNA:TLR9:MYD88
--
e36
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m36
0
infinite
0
--
IKK-i:TBK1
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
IKK-i:TBK1{active}
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
IRF-3{p}
--
e39
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m39
10
infinite
0
TRANSPATH | MO000041456 |
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
enhanceosome complex
--
e41
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m42
0
infinite
0
--
IFN-beta
--
e42
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m43
0
infinite
0
--
NF-kappaB{active}
--
e43
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m44
10
infinite
0
TRANSPATH | MO000000058 |
--
IFN-alpha
--
e44
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m45
0
infinite
0
--
ISGF3
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
ISGF3{active}
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
IFN-beta
--
e47
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m48
0
infinite
0
--
IRF7
--
e48
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m49
0
infinite
0
--
IRF-3{p}:pin1
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
TLR4:MD2
--
e5
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LPS:TLR4:MD2
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
IRF-3{p}{ub}:pin1
--
e63
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m64
0
infinite
0
--
SARM
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m65
0
infinite
0
--
SIKE
--
e65
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
IKK-i:SIKE:TBK1
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m67
0
infinite
0
--
JAK
--
e67
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m68
0
infinite
0
--
JAK{active}
--
e68
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m69
0
infinite
0
--
(stat1{p})2
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
(stat1{p})2
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
(stat1{p})2:IRF1SBE DNA
--
e71
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m72
0
infinite
0
--
IRF1SBE
--
e72
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m73
0
infinite
0
--
IRF7 ISRE:ISGF3{act}
--
e73
cso30:c:Complex
cso30:i:CC_Nucleolus
--
csml-variable:Double
m74
0
infinite
0
--
csml-variable:Double
m75
0
infinite
0
--
IRF1
--
e75
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m76
0
infinite
0
--
IFN-alpha1
--
e76
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m77
0
infinite
0
--
IFN-alpha1
--
e77
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m78
0
infinite
0
--
dsRNA:DDX58
--
e78
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
dsRNA:IFIH1
--
e79
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
dsRNA:DDX58:MAVS
--
e80
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m81
0
infinite
0
--
dsRNA:DDX58:MAVS:IKK
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m82
0
infinite
0
--
NF-kappaB
--
e82
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m83
10
infinite
0
TRANSPATH | MO000000058 |
--
IRF
--
e83
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m84
0
infinite
0
--
IRF{active}
--
e84
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m85
0
infinite
0
--
DAI
--
e85
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m86
0
infinite
0
--
DNA:DAI
--
e86
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m87
0
infinite
0
--
HLA-DR
--
e87
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m88
0
infinite
0
--
HLA-DR
--
e88
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m89
0
infinite
0
--
CD54
--
e89
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m90
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
CD54
--
e90
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m91
0
infinite
0
--
CD80
--
e91
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m92
0
infinite
0
--
CD80
--
e92
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m93
0
infinite
0
--
CD86
--
e93
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m94
0
infinite
0
--
CD86
--
e94
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m95
0
infinite
0
--
CXCL9
--
e95
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m96
0
infinite
0
--
CXCL9
--
e96
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m97
0
infinite
0
--
CXCL10
--
e97
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m98
0
infinite
0
--
CXCL11
--
e98
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m99
0
infinite
0
--
CXCL10
--
e99
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m100
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m5*m155666*0.1
nodelay
--
0
PMID: 18054516 TLR4 (together with its soluble coreceptor MD-2) binds Gram (¡Ý) bacteria-derived LPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m6*m19005*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m24*m18998*0.1
nodelay
--
0
PMID: 18054516, 16410796, 11544529 In the case of TLR4, another adaptor molecule, TRAM, is required to recruit TRIF to TLR4 and, in turn, to induce the pathway leading to the IFN-¦Â expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m26*m19940*0.1
nodelay
--
0
PMID: 18054516, 11812998, 12032557, 15661881 In addition to ssRNA, the synthetic imidazoquinoline, imiquimod, a low molecular weight immune response modifier, activates TLR7 in both humans and mice while its derivative resiquimod (R-848) activates TLR7 and TLR8 in humans, but only TLR7 in mice
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m28*m19823*0.1
nodelay
--
0
PMID: 18054516, 11812998, 12032557, 15661881 In addition to ssRNA, the synthetic imidazoquinoline, imiquimod, a low molecular weight immune response modifier, activates TLR7 in both humans and mice while its derivative resiquimod (R-848) activates TLR7 and TLR8 in humans, but only TLR7 in mice
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m19940*m28*0.1
nodelay
--
0
PMID: 18054516, 11812998, 12032557, 15661881 In addition to ssRNA, the synthetic imidazoquinoline, imiquimod, a low molecular weight immune response modifier, activates TLR7 in both humans and mice while its derivative resiquimod (R-848) activates TLR7 and TLR8 in humans, but only TLR7 in mice
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m6*m1572*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m18*m1572*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m11*m1572*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m19*m1572*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m21*m1572*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c6 : 1
stoichiometry:c5 : 1
m3964*m12*0.1
nodelay
--
0
PMID: 18054516 TLR2 recognizes peptidoglycan and lipopeptides
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m23*m1572*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c63 : 1
stoichiometry:c62 : 1
m37*m19305*0.1
nodelay
--
0
PMID: 18054516, 12702806, 14517278 This pathway mainly mediates the phosphorylation-induced activation of IRF-3 by two IkB kinase-related kinases, inhibitory protein kB kinase (IKK)-var epsilon and TANK binding kinase (TBK)1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c66 : 1
stoichiometry:c65 : 1
m37*m25*0.1
nodelay
--
0
PMID: 18054516, 12702806, 14517278 This pathway mainly mediates the phosphorylation-induced activation of IRF-3 by two IkB kinase-related kinases, inhibitory protein kB kinase (IKK)-var epsilon and TANK binding kinase (TBK)1
p23
p23
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c69 : 1
stoichiometry:c68 : 1
m977*m38*0.1
nodelay
--
0
PMID: 18054516, 12702806, 14517278 This pathway mainly mediates the phosphorylation-induced activation of IRF-3 by two IkB kinase-related kinases, inhibitory protein kB kinase (IKK)-var epsilon and TANK binding kinase (TBK)1
p24
p24
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c72 : 1
stoichiometry:c118 : 1
stoichiometry:c71 : 1
m980*m38*0.1
nodelay
--
0
PMID: 18054516, 16214811, 12821121 Recent reports have also shown that IRF-7 can be directly activated by TLR4 and TLR3 in IRF-3-deficient DC indicating that IRF-7 may potentiate the IRF-3-dependent induction of IFN-¦Â PMID: 18054516, 9786932, 9877175 Similar to IRF-3, IRF-7 undergoes serine phosphorylation by IKK-var epsilon and TBK1 followed by nuclear translocation PMID: 18054516, 16964262 Carty et al. recently demonstrated that a TIR adaptor SARM inhibits TRIF-induced IRF-7 activation in TLR3 or TLR4-stimulated cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m19324*0.1
nodelay
--
0
PMID: 18054516, 9786932, 9877175 Similar to IRF-3, IRF-7 undergoes serine phosphorylation by IKK-var epsilon and TBK1 followed by nuclear translocation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m19325*0.1
nodelay
--
0
PMID: 18054516, 9786932, 9877175 Similar to IRF-3, IRF-7 undergoes serine phosphorylation by IKK-var epsilon and TBK1 followed by nuclear translocation
p27
p27
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m39*m40*m41*m31298*0.1
nodelay
--
0
PMID: 18054516, 3329166, 16932750, 16979567 These events result in the assembly of the enhanceosome, a multiprotein complex consisting of ATF2/c-Jun, IRF-3/IRF-7, and NF-¦ÊB, all of which are required for the transcription of the IFN-¦Â gene
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m42*0.1
nodelay
--
0
PMID: 18054516, 3329166, 16932750, 16979567 These events result in the assembly of the enhanceosome, a multiprotein complex consisting of ATF2/c-Jun, IRF-3/IRF-7, and NF-¦ÊB, all of which are required for the transcription of the IFN-¦Â gene PMID: 18054516, 12077266, 14991609 In particular, the stimulation of TLR3 and TLR4 is associated mainly with the release of IFN-¦Â and a poor production of IFN-¦Á1 from human myeloid DC PMID: 18054516, 12077266, 14991609, 16846591 In myeloid DC the activation of IRF-3 following TLR3 or TLR4 triggering is responsible for the selective expression of IFN-¦Â and IFN-¦Á1 which contain in their promoter specific sequences recognizing this transcription factor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c86 : 1
stoichiometry:c85 : 1
m44*m31*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m13*m3964*0.1
nodelay
--
0
PMID: 18054516 TLR2 recognizes peptidoglycan and lipopeptides
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c89 : 1
stoichiometry:c88 : 1
m44*m34*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c92 : 1
stoichiometry:c91 : 1
m44*m35*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c95 : 1
stoichiometry:c94 : 1
m44*m36*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c98 : 1
stoichiometry:c97 : 1
m44*m32*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c101 : 1
stoichiometry:c100 : 1
m44*m33*0.1
nodelay
--
0
PMID: 18054516, 11544529, 17048703 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m48*m46*0.1
nodelay
--
0
PMID: 18054516, 9822609 While IRF-3 is constitutively expressed, IRF-7 expression is induced by IFN-¦Á/¦Â through the activation of IFN-stimulated gene factor (ISGF)-3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m45*m46*0.1
nodelay
--
0
PMID: 18054516, 9822609 While IRF-3 is constitutively expressed, IRF-7 expression is induced by IFN-¦Á/¦Â through the activation of IFN-stimulated gene factor (ISGF)-3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c146 : 1
m72*0.1
nodelay
--
0
PMID: 18054516 Among these, IRF-1 and IRF-7 are transcriptionally regulated by SBE and ISRE sites present within their respective promoters.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m39*m2065*0.1
nodelay
--
0
PMID: 18054516, 16699525 The peptidyl prolyl isomerase Pin1 interacts with IRF-3 in the nucleus and facilitates the conjugation of polyubiquitin and the proteasome-dependent degradation of IRF-3, thereby blocking the IFN-¦Â production downstream of TLR3, TLR4 and RIG-I pathways
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m63*0.1
nodelay
--
0
PMID: 18054516, 16699525 The peptidyl prolyl isomerase Pin1 interacts with IRF-3 in the nucleus and facilitates the conjugation of polyubiquitin and the proteasome-dependent degradation of IRF-3, thereby blocking the IFN-¦Â production downstream of TLR3, TLR4 and RIG-I pathways
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c12 : 1
stoichiometry:c11 : 1
m3966*m6485*0.1
nodelay
--
0
PMID: 18054516 TLR5 recognizes flagellin
p40
p40
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m64*0.1
nodelay
--
0
PMID: 18054516, 16699525 The peptidyl prolyl isomerase Pin1 interacts with IRF-3 in the nucleus and facilitates the conjugation of polyubiquitin and the proteasome-dependent degradation of IRF-3, thereby blocking the IFN-¦Â production downstream of TLR3, TLR4 and RIG-I pathways
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
stoichiometry:c121 : 1
m37*m66*0.1
nodelay
--
0
PMID: 18054516 Suppressor IKKvar epsilon (SIKE) is a suppressor that interacts with both TBK1 and IKKvar epsilon and sequester them in inactive complex.
p42
p42
cso30:i:ME_Dissociation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c125 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m67*m19314*0.1
nodelay
--
0
PMID: 18054516 Upon viral infection or TLR3 triggering, SIKE dissociates from TBK1 and IKKvar epsilon allowing type I IFN gene expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c130 : 1
stoichiometry:c131 : 1
m45*m68*0.1
nodelay
--
0
PMID: 18054516, 10817963 Once secreted from infected cells, IFNs induce in an autocrine and paracrine fashion the activation of Janus kinases (JAKs) and STAT transcription factors, leading to expression of IFN-stimulated genes (ISGs)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
stoichiometry:c129 : 1
m48*m68*0.1
nodelay
--
0
PMID: 18054516, 10817963 Once secreted from infected cells, IFNs induce in an autocrine and paracrine fashion the activation of Janus kinases (JAKs) and STAT transcription factors, leading to expression of IFN-stimulated genes (ISGs)
p45
p45
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c134 : 1
stoichiometry:c133 : 1
m1357*m69*0.1
nodelay
--
0
PMID: 18054516, 10817963 Once secreted from infected cells, IFNs induce in an autocrine and paracrine fashion the activation of Janus kinases (JAKs) and STAT transcription factors, leading to expression of IFN-stimulated genes (ISGs) PMID: 18054516 Upon phosphorylation and translocation into the nucleus, STAT bind as STAT-1 homodimer (GAF, IFN-¦Ã activated factor) to STAT binding element (SBE) or as heterotrimeric ISGF-3 complex (consisting of IRF-9, STAT-1 and STAT-2) to the IFN-stimulated response element (ISRE) in the promoter of target genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m4238*0.1
nodelay
--
0
PMID: 18054516 Upon phosphorylation and translocation into the nucleus, STAT bind as STAT-1 homodimer (GAF, IFN-¦Ã activated factor) to STAT binding element (SBE) or as heterotrimeric ISGF-3 complex (consisting of IRF-9, STAT-1 and STAT-2) to the IFN-stimulated response element (ISRE) in the promoter of target genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c138 : 1
m70*0.1
nodelay
--
0
PMID: 18054516 Upon phosphorylation and translocation into the nucleus, STAT bind as STAT-1 homodimer (GAF, IFN-¦Ã activated factor) to STAT binding element (SBE) or as heterotrimeric ISGF-3 complex (consisting of IRF-9, STAT-1 and STAT-2) to the IFN-stimulated response element (ISRE) in the promoter of target genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c141 : 1
stoichiometry:c140 : 1
m71*m73*0.1
nodelay
--
0
PMID: 18054516 Upon phosphorylation and translocation into the nucleus, STAT bind as STAT-1 homodimer (GAF, IFN-¦Ã activated factor) to STAT binding element (SBE) or as heterotrimeric ISGF-3 complex (consisting of IRF-9, STAT-1 and STAT-2) to the IFN-stimulated response element (ISRE) in the promoter of target genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c144 : 1
stoichiometry:c143 : 1
m47*m75*0.1
nodelay
--
0
PMID: 18054516 Upon phosphorylation and translocation into the nucleus, STAT bind as STAT-1 homodimer (GAF, IFN-¦Ã activated factor) to STAT binding element (SBE) or as heterotrimeric ISGF-3 complex (consisting of IRF-9, STAT-1 and STAT-2) to the IFN-stimulated response element (ISRE) in the promoter of target genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c15 : 1
stoichiometry:c14 : 1
m19940*m20*0.1
nodelay
--
0
PMID: 18054516, 14976261, 14976262 TLR7 and TLR8 recognize single-strand (ss)RNA and are also activated by infections with ssRNA viruses, including influenza virus and vesicular stomatitis virus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c145 : 1
m74*0.1
nodelay
--
0
PMID: 18054516, 9822609 While IRF-3 is constitutively expressed, IRF-7 expression is induced by IFN-¦Á/¦Â through the activation of IFN-stimulated gene factor (ISGF)-3 PMID: 18054516 Among these, IRF-1 and IRF-7 are transcriptionally regulated by SBE and ISRE sites present within their respective promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
m43*0.1
nodelay
--
0
PMID: 18054516, 12077266, 14991609 In particular, the stimulation of TLR3 and TLR4 is associated mainly with the release of IFN-¦Â and a poor production of IFN-¦Á1 from human myeloid DC PMID: 18054516, 12077266, 14991609, 16846591 In myeloid DC the activation of IRF-3 following TLR3 or TLR4 triggering is responsible for the selective expression of IFN-¦Â and IFN-¦Á1 which contain in their promoter specific sequences recognizing this transcription factor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c149 : 1
m39*0.1
nodelay
--
0
PMID: 18054516, 12077266, 14991609 In particular, the stimulation of TLR3 and TLR4 is associated mainly with the release of IFN-¦Â and a poor production of IFN-¦Á1 from human myeloid DC PMID: 18054516, 12077266, 14991609, 16846591 In myeloid DC the activation of IRF-3 following TLR3 or TLR4 triggering is responsible for the selective expression of IFN-¦Â and IFN-¦Á1 which contain in their promoter specific sequences recognizing this transcription factor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c152 : 1
m77*0.1
nodelay
--
0
PMID: 18054516, 12077266, 14991609 In particular, the stimulation of TLR3 and TLR4 is associated mainly with the release of IFN-¦Â and a poor production of IFN-¦Á1 from human myeloid DC PMID: 18054516, 12077266, 14991609, 16846591 In myeloid DC the activation of IRF-3 following TLR3 or TLR4 triggering is responsible for the selective expression of IFN-¦Â and IFN-¦Á1 which contain in their promoter specific sequences recognizing this transcription factor
p54
p54
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c154 : 1
stoichiometry:c155 : 1
m119368*m41844*0.1
nodelay
--
0
PMID: 18054516 During a viral infection, RIG-1 and MDA5 are activated upon detection of dsRNA by the RNA helicase domain, and trigger the activation of NF-¦ÊB and IRF3/7, which cooperate in the induction of type I IFNs
p55
p55
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
m119368*m76904*0.1
nodelay
--
0
PMID: 18054516 During a viral infection, RIG-1 and MDA5 are activated upon detection of dsRNA by the RNA helicase domain, and trigger the activation of NF-¦ÊB and IRF3/7, which cooperate in the induction of type I IFNs
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c161 : 1
stoichiometry:c160 : 1
m79*m68199*0.1
nodelay
--
0
PMID: 18054516, 16177806, 16125763, 16127453, 16039576 It has been proposed that once activated by dsRNA, RIG-I interacts with IPS-1 via their respective CARD domains, resulting in the recruitment of appropriate signalling intermediates, such as IKKs for NF-¦ÊB and IRF activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
stoichiometry:c164 : 1
m81*m207*0.1
nodelay
--
0
PMID: 18054516, 16177806, 16125763, 16127453, 16039576 It has been proposed that once activated by dsRNA, RIG-I interacts with IPS-1 via their respective CARD domains, resulting in the recruitment of appropriate signalling intermediates, such as IKKs for NF-¦ÊB and IRF activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c167 : 1
stoichiometry:c166 : 1
m83*m82*0.1
nodelay
--
0
PMID: 18054516, 16177806, 16125763, 16127453, 16039576 It has been proposed that once activated by dsRNA, RIG-I interacts with IPS-1 via their respective CARD domains, resulting in the recruitment of appropriate signalling intermediates, such as IKKs for NF-¦ÊB and IRF activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c170 : 1
stoichiometry:c169 : 1
m84*m82*0.1
nodelay
--
0
PMID: 18054516, 16177806, 16125763, 16127453, 16039576 It has been proposed that once activated by dsRNA, RIG-I interacts with IPS-1 via their respective CARD domains, resulting in the recruitment of appropriate signalling intermediates, such as IKKs for NF-¦ÊB and IRF activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m19823*m20*0.1
nodelay
--
0
PMID: 18054516, 14976261, 14976262 TLR7 and TLR8 recognize single-strand (ss)RNA and are also activated by infections with ssRNA viruses, including influenza virus and vesicular stomatitis virus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c171 : 1
stoichiometry:c172 : 1
stoichiometry:c173 : 1
m22*m86*0.1
nodelay
--
0
PMID: 18054516, 17618271 The very recent identification of DNA-dependent activator of IRF (DAI) as a cytosolic DNA sensor able to induce type I IFN expression following the recognition of different sources of microbial DNA, provides an explanation of how different pathogens may induce type I IFN genes through a unique pathway
PMID: 18054516, 15101709, 16769767, 12513906 type I IFNs promote the differentiation of human blood monocytes into DC and contribute to their maturation
PMID: 18054516, 15101709, 16769767, 12513906 type I IFNs promote the differentiation of human blood monocytes into DC and contribute to their maturation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c178 : 1
m45*0.1
nodelay
--
0
PMID: 18054516, 15101709, 16769767, 12513906 In particular, it was reported that blood monocytes maintained in culture for 3 days with IFN-¦Á express high levels of HLA-DR, of costimulatory molecules CD80, CD86 and of adhesion molecule CD54
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c180 : 1
stoichiometry:c176 : 1
m88*m45*0.1
nodelay
--
0
PMID: 18054516, 15101709, 16769767, 12513906 In particular, it was reported that blood monocytes maintained in culture for 3 days with IFN-¦Á express high levels of HLA-DR, of costimulatory molecules CD80, CD86 and of adhesion molecule CD54
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c183 : 1
m45*0.1
nodelay
--
0
PMID: 18054516, 15101709, 16769767, 12513906 In particular, it was reported that blood monocytes maintained in culture for 3 days with IFN-¦Á express high levels of HLA-DR, of costimulatory molecules CD80, CD86 and of adhesion molecule CD54
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c185 : 1
stoichiometry:c181 : 1
m90*m45*0.1
nodelay
--
0
PMID: 18054516, 15101709, 16769767, 12513906 In particular, it was reported that blood monocytes maintained in culture for 3 days with IFN-¦Á express high levels of HLA-DR, of costimulatory molecules CD80, CD86 and of adhesion molecule CD54
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c186 : 1
m45*0.1
nodelay
--
0
PMID: 18054516, 15101709, 16769767, 12513906 In particular, it was reported that blood monocytes maintained in culture for 3 days with IFN-¦Á express high levels of HLA-DR, of costimulatory molecules CD80, CD86 and of adhesion molecule CD54
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c189 : 1
stoichiometry:c190 : 1
stoichiometry:c188 : 1
m92*m45*0.1
nodelay
--
0
PMID: 18054516, 15101709, 16769767, 12513906 In particular, it was reported that blood monocytes maintained in culture for 3 days with IFN-¦Á express high levels of HLA-DR, of costimulatory molecules CD80, CD86 and of adhesion molecule CD54
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c193 : 1
stoichiometry:c192 : 1
m94*m45*0.1
nodelay
--
0
PMID: 18054516, 15101709, 16769767, 12513906 In particular, it was reported that blood monocytes maintained in culture for 3 days with IFN-¦Á express high levels of HLA-DR, of costimulatory molecules CD80, CD86 and of adhesion molecule CD54
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 18054516 TLR3 is triggered by double-strand (ds)RNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c195 : 1
stoichiometry:c194 : 1
m45*0.1
nodelay
--
0
PMID: 18054516, 15101709, 16769767, 12513906 In particular, it was reported that blood monocytes maintained in culture for 3 days with IFN-¦Á express high levels of HLA-DR, of costimulatory molecules CD80, CD86 and of adhesion molecule CD54
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c196 : 1
stoichiometry:c197 : 1
m45*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c198 : 1
stoichiometry:c199 : 1
m48*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c204 : 1
stoichiometry:c200 : 1
m96*m45*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c205 : 1
stoichiometry:c201 : 1
m96*m48*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c206 : 1
m45*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c222 : 1
stoichiometry:c207 : 1
m48*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c220 : 1
stoichiometry:c208 : 1
m99*m45*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c211 : 1
stoichiometry:c224 : 1
stoichiometry:c209 : 1
m99*m48*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c214 : 1
stoichiometry:c221 : 1
stoichiometry:c212 : 1
m98*m45*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m19828*m22*0.1
nodelay
--
0
PMID: 18054516 TLR9 is known to bind unmethylated bacterial and viral dsDNA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c215 : 1
stoichiometry:c225 : 1
stoichiometry:c213 : 1
m98*m48*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c219 : 1
stoichiometry:c216 : 1
m45*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c223 : 1
stoichiometry:c217 : 1
m48*0.1
nodelay
--
0
PMID: 18054516 In particular, the expression of CXCR3 binding chemokines, CXCL9, CXCL10 and CXCL11, is dependent on type I IFNs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c230 : 1
stoichiometry:c231 : 1
stoichiometry:c226 : 1
m104*0.1
nodelay
--
0
PMID: 18054516, 10604988 On the other hand, CD40-dependent IL-12 production from monocyte-derived DC was shown to be impaired by IFN-¦Â
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c227 : 1
stoichiometry:c229 : 1
stoichiometry:c232 : 1
stoichiometry:c228 : 1
m102*m104*0.1
nodelay
--
0
PMID: 18054516, 10604988 On the other hand, CD40-dependent IL-12 production from monocyte-derived DC was shown to be impaired by IFN-¦Â
p85
p85
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c236 : 1
stoichiometry:c238 : 1
stoichiometry:c234 : 1
m105*m19314*0.1
nodelay
--
0
PMID: 18054516, 16624932 Among the STAT transcription factors involved in type I IFN signalling, STAT-1 and -2 contents are increased in DC stimulated with LPS or poly I:C
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c235 : 1
stoichiometry:c237 : 1
stoichiometry:c233 : 1
m105*m6*0.1
nodelay
--
0
PMID: 18054516, 16624932 Among the STAT transcription factors involved in type I IFN signalling, STAT-1 and -2 contents are increased in DC stimulated with LPS or poly I:C
p87
p87
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c240 : 1
stoichiometry:c244 : 1
stoichiometry:c241 : 1
m94507*m19314*0.1
nodelay
--
0
PMID: 18054516, 16624932 Among the STAT transcription factors involved in type I IFN signalling, STAT-1 and -2 contents are increased in DC stimulated with LPS or poly I:C
p88
p88
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c239 : 1
stoichiometry:c243 : 1
stoichiometry:c242 : 1
m94507*m6*0.1
nodelay
--
0
PMID: 18054516, 16624932 Among the STAT transcription factors involved in type I IFN signalling, STAT-1 and -2 contents are increased in DC stimulated with LPS or poly I:C
p89
p89
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c245 : 1
stoichiometry:c246 : 1
m41*0.1
nodelay
--
0
PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m19314*m18998*0.1
nodelay
--
0
PMID: 18054516, 11544529, 16410796 With the exception of TLR3, which signals solely by TRIF, all TLRs recruit MyD88, which triggers signalling pathways leading to nuclear translocation of NF-¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c247 : 1
stoichiometry:c248 : 1
m94523*0.1
nodelay
--
0
PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
p91
p91
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c249 : 1
stoichiometry:c251 : 1
stoichiometry:c250 : 1
m2053*m45*0.1
nodelay
--
0
PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c252 : 1
stoichiometry:c253 : 1
m106*0.1
nodelay
--
0
PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c254 : 1
stoichiometry:c256 : 1
stoichiometry:c255 : 1
m83*m11*0.1
nodelay
--
0
PMID: 18054516 STAT-4 expression can be induced in human primary DC by multiple stimuli activating NF-¦ÊB transcription factors, such as the ligands for TLR4, TLR2 and TLR3, various pathogens, CD40L and the pro-inflammatory cytokines TNF-¦Á and IL-1¦Â. PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
p94
p94
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c257 : 1
stoichiometry:c259 : 1
stoichiometry:c258 : 1
m83*m19314*0.1
nodelay
--
0
PMID: 18054516 STAT-4 expression can be induced in human primary DC by multiple stimuli activating NF-¦ÊB transcription factors, such as the ligands for TLR4, TLR2 and TLR3, various pathogens, CD40L and the pro-inflammatory cytokines TNF-¦Á and IL-1¦Â. PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c260 : 1
stoichiometry:c262 : 1
stoichiometry:c261 : 1
m83*m6*0.1
nodelay
--
0
PMID: 18054516 STAT-4 expression can be induced in human primary DC by multiple stimuli activating NF-¦ÊB transcription factors, such as the ligands for TLR4, TLR2 and TLR3, various pathogens, CD40L and the pro-inflammatory cytokines TNF-¦Á and IL-1¦Â. PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
p96
p96
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c263 : 1
stoichiometry:c265 : 1
stoichiometry:c264 : 1
m83*m230*0.1
nodelay
--
0
PMID: 18054516 STAT-4 expression can be induced in human primary DC by multiple stimuli activating NF-¦ÊB transcription factors, such as the ligands for TLR4, TLR2 and TLR3, various pathogens, CD40L and the pro-inflammatory cytokines TNF-¦Á and IL-1¦Â. PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c266 : 1
stoichiometry:c268 : 1
stoichiometry:c267 : 1
m83*m108*0.1
nodelay
--
0
PMID: 18054516 STAT-4 expression can be induced in human primary DC by multiple stimuli activating NF-¦ÊB transcription factors, such as the ligands for TLR4, TLR2 and TLR3, various pathogens, CD40L and the pro-inflammatory cytokines TNF-¦Á and IL-1¦Â. PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c269 : 1
stoichiometry:c271 : 1
stoichiometry:c270 : 1
m83*m109*0.1
nodelay
--
0
PMID: 18054516 STAT-4 expression can be induced in human primary DC by multiple stimuli activating NF-¦ÊB transcription factors, such as the ligands for TLR4, TLR2 and TLR3, various pathogens, CD40L and the pro-inflammatory cytokines TNF-¦Á and IL-1¦Â. PMID: 18054516 Thus, under inflammatory conditions, NF-¦ÊB is activated and, in turn, induces STAT-4 whose activation by type I IFNs may regulate the transcription of specific target genes in mature DC.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--